Results 11 to 20 of about 9,800 (200)
Pubertal Assessment and Growth in Patients With Hemoglobinopathies: A Longitudinal Multicenter Study on the Association With Ferritin Levels [PDF]
European Journal of Haematology, EarlyView.ABSTRACT Objectives Although Advancements in the Treatment of Hemoglobinopathies have Considerably Increased Life Expectancy, Hormonal and Pubertal Development Have Been Continuously Affected by Complications From Transfusion‐Related Iron Overload and Cytotoxic Therapies.
Jill Dülberg +20 more
openalex +2 more sources
A Novel Alpha1-Variant (HBA1:c.-35T>C) Complexed With the First Reported Hb M-Saskatoon in the Chinese Population. [PDF]
Mol Genet Genomic MedThe research subjects were diagnosed with two distinct types of abnormal hemoglobin. Our study reports the first case of a complex hemoglobinopathy in China, characterized by the presence of the globally first‐reported alpha1 variant (HBA1:c.‐35T>C) and the initial identification of Hb M‐Saskatoon (HBB:c.190C>T) in China.
Yang Y +5 more
europepmc +2 more sources
Hemoglobinopathy SD presenting as Hemoglobinopathy SS
Medicina, 2017 This case report shows the interaction of hemoglobin (Hb) S with Hb D. in a child previously diagnosed with sickle cell anemia based on the Hb electrophoretic migration pattern in alkaline pH.
Sonia Maria Lissa +4 more
doaj +1 more source
Distribution of Hemoglobinopathy in Nepalese Population
Journal of Nepal Health Research Council, 2020 Background: Sickle cell and thalassemia are the inherited disorders of globin chain synthesis, and are the most common monogenic disease worldwide. This study aims to find the distribution of hemoglobinopathies (sickle cell and thalassemia) cases in ...
Rekha Manandhar Shrestha +5 more
doaj +1 more source
Bromhexine is a potential drug for COVID-19; From hypothesis to clinical trials
Вопросы вирусологии, 2022 COVID-19 (novel coronavirus disease 2019), caused by the SARS-CoV-2 virus, has various clinical manifestations and several pathogenic pathways. Although several therapeutic options have been used to control COVID-19, none of these medications have been ...
S. Bahadoram +6 more
doaj +1 more source
Hematology Reports, 2018 Beta thalassemia dominant results from mutations in the β globin chain gene resulting in the production of elongated, highly unstable beta globin chains.
Alexandra Agapidou +3 more
doaj +1 more source
Treatment Status of Patients with Β-Thalassemia Major in Northern Iran: Thalassemia Registry System
Iranian Journal of Public Health, 2019 Background: Electronic registry system of beta-thalassemia patients was run by Thalassemia Research Center (TRC) in 2017. The aim of the current study was presentation of therapeutic status in these patients at Mazandaran Province, Iran.
Mehrnoush KOSARYAN +5 more
doaj +1 more source
Review of clinical and hematological profile of hemoglobin D cases in a single centre
Journal of Marine Medical Society, 2023 Introduction: Hemoglobin D Punjab is a common hemoglobin D variant, which is essentially known to cause a mild disease even in homozygous state. Heterozygous state of hemoglobin D Punjab with sickle cell is the only presentation when a severe disease may
Neha Singh, Tulika Seth, Seema Tyagi
doaj +1 more source
Transfusion-induced hemoglobinopathy in patients of beta-thalassemia major
Indian Journal of Pathology and Microbiology, 2011 Apparent hemoglobinopathy acquired after blood transfusion is an uncommon cause of diagnostic dilemma resulting in repeated testing and delay in the diagnosis.
Sanjeev K Gupta +3 more
doaj +1 more source
Parasite, 2021 Background: Artemisinin-based treatment in malaria patients with abnormal hemoglobin may be ineffective because of their genetic particularity, which could lead to resistance.
Gbessi Eric A. +10 more
doaj +1 more source